Health News
Boehringer checking deaths among users of anti-stroke drug
Nov 2, 2011, 18:44 GMT
Ingelheim, Germany - German pharmaceuticals company Boehringer Ingelheim said Wednesday that some patients using its anti-stroke medication Pradaxa had died, and said it was investigating the cause.
The drug, which first went on sale last year in the United States, counters blood clotting.
'There are reported cases in Germany and/or in Europe,' said company spokesman Reinhard Malin, confirming a report set to appear Thursday in weekly newspaper Die Zeit. He said he could not disclose numbers because the data was still being studied.
Die Zeit reported that Boehringer Ingelheim urged doctors last month to regularly test patients on the drug if they were aged over 75 and suffered from kidney disease. It said Boehringer had confirmed 14 deaths in Japan of patients who had previously used the drug.
COMMENT
blog comments powered by DisqusLatest Headlines in Health
- 1. US Supreme Court to decide fate of healthcare law
- 2. Obama's health law hangs in balance with skeptical court
- 3. Supreme Court begins hearing on Obama's landmark health law
- 4. China vows to end transplants from executed prisoners
- 5. Nordic walking a simple way to get fit
Older Talkback
